HASI outlines 2028 adjusted EPS of $3.50-$3.60 and 17% adjusted ROE while launching $400M Neogenyx JV
HASI reported a strong Q1 2026 with adjusted EPS of $0.77 and adjusted ROE of 15.7%. The company announced a $400 million joint venture, Neogenyx, with Ameresco, aiming for a 2028 adjusted EPS of $3.50-$3.60 and 17% ROE. They closed over $460 million in new transactions and increased fee-generating assets by 130% year-over-year to $1.1 billion. Adjusted recurring net investment income rose 29% to $101 million, with managed assets up 13% to $16.4 billion. The company maintains a robust pipeline exceeding $6.5 billion and has $2.3 billion in available liquidity.
Source: businessinsider The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments